AI-driven deep learning models surpass expert radiologists in diagnosing kidney tumors using CT scans. The study highlights ...

Personalized vaccine targets key driver mutations and induces antitumor immunity in fully resected high-risk clear cell renal cell carcinoma.

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

A poorly positioned menstrual cup to capture monthly blood flow may lead to more serious complications than leakage alone, warn doctors in the journal BMJ Case Reports, after treating a young woman ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

However, I think that is something we have to balance in our clinic. I see patients with kidney cancer every week, [and have to ensure transparency when discussing] where we are today — we have to be ...

Germ Cell Tumor Market Outlook 2025-2035: The 7 major germ cell tumor market reached a value of USD 1.6 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 4.2 Billion by 2035, ...

Endometrial Cancer Market Outlook 2025-2035: The 7 major endometrial cancer market reached a value of USD 21.4 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 31.2 Billion ...